Mona A. Fouad

Lotfy Elsayed Street
Cairo, C 11331, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Added value of contrast-enhanced mammography in assessment of breast asymmetries.

Added value of contrast-enhanced mammography in assessment of breast asymmetries.

Journal: The British journal of radiology

Published: April 02, 2019

A network meta-analysis of the risk of immune-related renal toxicity in cancer patients treated with immune checkpoint inhibitors.

A network meta-analysis of the risk of immune-related renal toxicity in cancer patients treated with immune checkpoint inhibitors.

Journal: Immunotherapy

Published: May 04, 2016

Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis.

Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis.

Journal: Therapeutic advances in respiratory disease

Published: March 06, 2016

Rolapitant: a pooled analysis of its efficacy and safety in the prophylaxis of chemotherapy-induced nausea and vomiting.

Rolapitant: a pooled analysis of its efficacy and safety in the prophylaxis of chemotherapy-induced nausea and vomiting.

Journal: Future oncology (London, England)

Published: January 26, 2016

Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis.

Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis.

Journal: Future oncology (London, England)

Published: January 19, 2016

Risk of gastrointestinal complications in cancer patients treated with immune checkpoint inhibitors: a meta-analysis.

Risk of gastrointestinal complications in cancer patients treated with immune checkpoint inhibitors: a meta-analysis.

Journal: Immunotherapy

Published: October 30, 2015

Irinotecan-based regimens for recurrent glioblastoma multiforme: [corrected] a systematic review.

Irinotecan-based regimens for recurrent glioblastoma multiforme: [corrected] a systematic review.

Journal: Expert review of neurotherapeutics

Published: October 16, 2015

Risk of elevated transaminases in cancer patients treated with immune checkpoint inhibitors: a meta-analysis.

Risk of elevated transaminases in cancer patients treated with immune checkpoint inhibitors: a meta-analysis.

Journal: Expert opinion on drug safety

Published: September 24, 2015

Risk of cutaneous toxicities in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis.

Risk of cutaneous toxicities in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis.

Journal: Future oncology (London, England)

Published: August 15, 2015

Systemic therapy options for advanced gastrointestinal stromal tumors beyond first-line imatinib: a systematic review.

Systemic therapy options for advanced gastrointestinal stromal tumors beyond first-line imatinib: a systematic review.

Journal: Future oncology (London, England)

Published: June 16, 2015

Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with everolimus, temsirolimus or ridaforolimus: a comparative systematic review and meta-analysis.

Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with everolimus, temsirolimus or ridaforolimus: a comparative systematic review and meta-analysis.

Journal: Expert review of anticancer therapy

Published: May 22, 2015

Temozolomide-based combination for advanced neuroendocrine neoplasms: a systematic review of the literature.

Temozolomide-based combination for advanced neuroendocrine neoplasms: a systematic review of the literature.

Journal: Future oncology (London, England)

Published: April 03, 2015

Showing 1-12 of 30

Last Updated: 09/26/2026